Home › Idiopathic Pulmonary Fibrosis › Tennessee
Pag-aaral pangklinika para sa Idiopathic Pulmonary Fibrosis sa Tennessee
6 pag-aaral para sa Idiopathic Pulmonary Fibrosis ang naghahanap ng mga kalahok sa mga site sa Tennessee.
Mga Lungsod sa Tennessee
Opisyal na teksto ng pag-aaral (English)
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- Vanderbilt University Medical Center, Nashville
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06951217RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Alliance for Multispecialty Research Clinical, Knoxville
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07002034Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Clinical Trials Center of Middle Tennesee LLC, Franklin
Nagre-recruitPhase 3
Edad 40 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284602Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Vanderbilt University, Nashville
Nagre-recruitObservasyonal na pag-aaral
Edad 21 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer Site in Nashville, TN, Nashville
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06967805Mechanisms of Familial Pulmonary Fibrosis
- Vanderbilt University Medical Center, Nashville
Nagre-recruitObservasyonal na pag-aaral
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Dis 31, 2025 · NCT03437486Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.